Alyeska Investment Group, L.P. Aptevo Therapeutics Inc. Call Options Transaction History

Alyeska Investment Group, L.P.

  • $18 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.17 - $0.38 $7,816 - $17,472
45,980 New
45,980 $8,000
Q1 2021

May 17, 2021
SELL
$27.86 - $40.59 $62,935 - $91,692
-2,259 Reduced 0.35%
643,723 $19.6 Million
Q2 2020

Aug 14, 2020
SELL
$3.11 - $9.27 $323,495 - $964,246
-104,018 Reduced 13.87%
645,982 $5.39 Million
Q1 2020

May 15, 2020
BUY
$3.29 - $9.73 $2.47 Million - $7.3 Million
750,000 New
750,000 $2.78 Million

About Aptevo Therapeutics Inc.

APVO Quotes by TradingView
  • Ticker APVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,090,640
  • Market Cap $24.2M
  • Description
  • Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...
More about APVO
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email